Stephen Knight

Stephen joined F-Prime Capital in 2003 where he serves as President and Managing Partner.

Stephen worked in the pharmaceutical and biotechnology industries for over 25 years and invest broadly across healthcare. He serves on the Board of Directors of Beam Therapeutics, Iora Health, Pulmocide, Sana Biotechnology, Geneception, and Semma Therapeutics. Stephen held various senior management roles in private and public biotechnology and consulting companies, and also has experience in the research sector.